Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 1/20 | 0.67 |
| ▸ | PLAU | P00749 | 1/20 | 0.67 |
| ▸ | ST14 | Q9Y5Y6 | 1/20 | 0.67 |
| ▸ | POLB | P06746 | 3/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.65 |
| ▸ | LMNA | P02545 | 2/20 | 0.65 |
| ▸ | RAB9A | P51151 | 2/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.65 |
| ▸ | MAPT | P10636 | 2/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.65 |
| ▸ | NPC1 | O15118 | 1/20 | 0.65 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.65 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.65 |
| ▸ | HTT | P42858 | 1/20 | 0.65 |
| ▸ | GMNN | O75496 | 1/20 | 0.65 |
| ▸ | PKM | P14618 | 1/20 | 0.65 |
| ▸ | THPO | P40225 | 1/20 | 0.65 |
| ▸ | MTOR | P42345 | 1/20 | 0.65 |
| ▸ | RECQL | P46063 | 1/20 | 0.65 |
| ▸ | BLM | P54132 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20528835 | 1.00 | F2 (0.67) | F2PLAUST14POLBALDH1A1 | |
| SCHEMBL3006160 | 1.00 | F2 (0.67) | F2PLAUST14POLBALDH1A1 | |
| Dibrompropamidine SCHEMBL30231952 | 0.96 | F2 (0.72) | F2PLAUST14POLBALDH1A1 | |
| Dibrompropamidine SCHEMBL871570 | 0.96 | F2 (0.72) | F2PLAUST14POLBALDH1A1 | |
| Dibrompropamidine SCHEMBL2471251 | 0.96 | F2 (0.72) | F2PLAUST14POLBALDH1A1 | |
| SCHEMBL14599538 | 0.85 | F2 (0.90) | F2PLAUST14PRSS1KLK1 | |
| SCHEMBL597315 | 0.85 | F2 (0.90) | F2PLAUST14PRSS1KLK1 | |
| Dibrompropamidine SCHEMBL29709297 | 0.81 | F2 (1.00) | F2PLAUST14PRSS1 | |
| Dibrompropamidine SCHEMBL292947 | 0.81 | F2 (1.00) | F2PLAUST14PRSS1 | |
| Dibrompropamidine SCHEMBL29232796 | 0.81 | F2 (0.71) | F2PLAUST14PRSS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11666050-B2 | Enhancing the antimicrobial activity of biocides with polymers | BASF SE (DE) | 2023-06-06 | — | — | US | disclosed |
| US-11647746-B2 | Enhancing the antimicrobial activity of biocides with polymers | BASF SE (DE) | 2023-05-16 | — | — | US | disclosed |
| EP-3769624-A2 | ENHANCING THE ANTIMICROBIAL ACTIVITY OF BIOCIDES WITH POLYMERS | BASF SE (DE) | 2021-01-27 | — | — | EP | disclosed |
| US-20200221694-A1 | Enhancing the Antimicrobial Activity of Biocides with Polymers | BASF SE (DE) | 2020-07-16 | — | — | US | disclosed |
| US-20170121534-A1 | USE OF GAMMA IRON(III) OXIDE (GAMMA-FE2O3) CONTAINING PARTICLES FOR THE PREVENTION OF BIOFOULING AND/OR GROWTH OF MICROORGANISMS | BASF SE (DE) | 2017-05-04 | — | — | US | disclosed |
| EP-3157333-A1 | USE OF GAMMA IRON(III) OXIDE (GAMMA-FE2O3) CONTAINING PARTICLES FOR THE PREVENTION OF BIOFOULING AND/OR GROWTH OF MICROORGANISMS | BASF SE (DE) | 2017-04-26 | — | — | EP | disclosed |
| US-20160113283-A1 | USE OF VANADIUM-CONTAINING PARTICLES AS A BIOCIDE | BASF SE (DE) | 2016-04-28 | — | — | US | disclosed |
| EP-3003028-A1 | USE OF VANADIUM-CONTAINING PARTICLES AS A BIOCIDE | BASF SE (DE) | 2016-04-13 | — | — | EP | disclosed |
| WO-2015193134-A1 | USE OF GAMMA IRON(III) OXIDE (GAMMA-FE2O3) CONTAINING PARTICLES FOR THE PREVENTION OF BIOFOULING AND/OR GROWTH OF MICROORGANISMS | BASF SE (DE) | 2015-12-23 | — | — | WO | disclosed |
| EP-2817353-A1 | ENHANCING THE ANTIMICROBIAL ACTIVITY OF BIOCIDES WITH POLYMERS | BASF SE (DE) | 2014-12-31 | — | — | EP | disclosed |
| WO-2004020530-A1 | COLOURED GLOSS PIGMENTS HAVING AT LEAST ONE COATING OF SIOX, WITH X=0.03 TO 0.95 FOR USE IN COSMETIC AND PERSONAL CARE FORMULATIONS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2004-03-11 | — | — | WO | disclosed |
| WO-2004019896-A1 | METHOD OF COLOURING POROUS MATERIAL | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2004-03-11 | — | — | WO | disclosed |
| US-20030207884-A1 | Use of phenylethylamine derivatives for the antimicrobial treatment of surfaces | CIBA SPECIALTY CHEMICALS CORP. | 2003-11-06 | — | — | US | disclosed |
| WO-2003076518-A2 | PROCESS FOR EXCHANGING THE ANIONS OF CATIONIC COMPOUNDS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2003-09-18 | — | — | WO | disclosed |
| WO-2003070207-A1 | METHOD OF COLOURING KERATIN-CONTAINING FIBRES | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2003-08-28 | — | — | WO | disclosed |
| WO-2003060015-A1 | YELLOW CATIONIC DYES FOR DYING OF ORGANIC MATERIAL | CIBA SPECIALITY CHEMICALS HOLDING INC. (CH) | 2003-07-24 | — | — | WO | disclosed |
| WO-2003032939-A1 | METHOD OF COLOURING KERATIN-CONTAINING FIBRES USING DIAZONIUM SALTS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2003-04-24 | — | — | WO | disclosed |
| WO-2003029359-A1 | CATIONIC REACTIVE DYES | CIBA SPECIALTY CHEMICALS HOLDINGS INC. (CH) | 2003-04-10 | — | — | WO | disclosed |
| EP-1265483-A2 | USE OF PHENYLETHYLAMINE DERIVATIVES FOR THE ANITMICROBIAL TREATMENT OF SURFACES | Ciba SC Holding AG (CH) | 2002-12-18 | — | — | EP | disclosed |
| WO-2001062082-A2 | USE OF PHENYLETHYLAMINE DERIVATIVES FOR THE ANITMICROBIAL TREATMENT OF SURFACES | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2001-08-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160113283-A1 | USE OF VANADIUM-CONTAINING PARTICLES AS A BIOCIDE | VCL, LPO, VAC14 | F2 1306/4885PLAU 2725/4885ST14 380/4885 |
| US-11647746-B2 | Enhancing the antimicrobial activity of biocides with polymers | CAT, AOC1, DDT | F2 931/4885PLAU 1402/4885ST14 2195/4885 |
| US-20030207884-A1 | Use of phenylethylamine derivatives for the antimicrobial treatment of surfaces | CLTC, TUBA3C, AOC1 | F2 3559/4885PLAU 3851/4885ST14 1433/4885 |
| US-11666050-B2 | Enhancing the antimicrobial activity of biocides with polymers | CAT, AOC1, DDT | F2 931/4885PLAU 1402/4885ST14 2195/4885 |
| US-20200221694-A1 | Enhancing the Antimicrobial Activity of Biocides with Polymers | CAT, AOC1, DDT | F2 931/4885PLAU 1402/4885ST14 2195/4885 |
| US-20170121534-A1 | USE OF GAMMA IRON(III) OXIDE (GAMMA-FE2O3) CONTAINING PARTICLES FOR THE PREVENTION OF BIOFOULING AND/OR GROWTH OF MICROORGANISMS | LPO, TFRC, LBR | F2 114/4885PLAU 2768/4885ST14 2433/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.